Biotechnology Stocks I Performance Guide: Genmab A/S (GMAB)
GMAB has no dividends.
Table and Chart of GMAB Performance
See what a $1,000 investment in GMAB is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| GMAB Returns | |
|---|---|
| Start Date | Jul-31-2014 |
| Start Price | $4.03 |
| End Date | Jul-26-2024 |
| End Price | $28.38 |
| # Prices | 121 |
| Min Date | Jul-31-2014 |
| Min Price | $4.03 |
| Max Date | Aug-31-2021 |
| Max Price | $47.39 |
| Total Return | 603.87% |
| Annualized Return | 21.35% |
| Current Value of $1,000 Purchase | $7,039 |
| Number Returns | 7,260 |
| Average Return | 116.76% |
| Number Profitable Returns | 5,999 |
| Percent Profitable Returns | 82.63% |
| Number Unprofitable Returns | 1,261 |
| Percent Unprofitable Returns | 17.37% |
| Profitable to Unprofitable Returns Ratio | 4.76 |
| GMAB Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $17,852,957,000 |
| Beta | 0.828 | Price to Sales | 1.17 |
| Earnings per Share | $1.2100 |
| PE Ratio | 23.25 |
| PE to Growth Ratio | 1.273 |
| Price to Book | 4.185 |
| PRICE DATA | |
| 52 Week High | $41.58 |
| 52 Week Low | $24.53 |
| Analyst Target Price | $41.53 |
| 50-Day Moving Average | $27.27 |
| 200-Day Moving Average | $29.3 |
| FINANCIAL DATA | |
| Revenue per Share | $27.24 |
| Revenue | $17,782,999,000 |
| Profit Margin | 30.7% |
| Return on Equity | 18.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
GMAB Compare Returns with S&P 500
GMAB Trendline Chart
GMAB Moving Average Chart
GMAB Stock Return Map - See Patterns of Gains and Losses
GMAB Stock Returns/Purchase Dates